Abel Moron, MD
Gynecologic Oncology · Arlington, TXNPI 1033435367
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.4% of the total across 89 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 29 manufacturers, the largest accounting for just 19.9% — the pattern of someone who eats at a lot of different presentations. That places this record below the midpoint for gynecologic oncology clinicians in TX, where the typical reported total is $3,034.
Across 89 payments — averaging $36.48 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Myriad Genetic Laboratories, Inc.$647
- Dilon Technologies, Inc.$477
- GSK$340
- Stryker$272
- AstraZeneca$214
- Biom'up France SAS$185
- plus $1K from 23 others
What the payments were for
- Food & beverage$3,22799%
- Education$201%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Myriad Genetic Laboratories, Inc. | 10 | $647 |
| Dilon Technologies, Inc. | 3 | $477 |
| GSK | 9 | $340 |
| Stryker | 2 | $272 |
| AstraZeneca | 12 | $214 |
| Biom'up France SAS | 2 | $185 |
| Tesaro, Inc. | 7 | $165 |
| Clovis Oncology, Inc. | 8 | $131 |
| Amgen | 5 | $102 |
| Boston Scientific | 2 | $95 |
| Merck | 4 | $73 |
| Heron Therapeutics, Inc. | 3 | $64 |
| Novartis | 3 | $52 |
| Incyte Corporation | 2 | $42 |
| Kyowa Kirin, Inc. | 2 | $42 |
| Genmab U.S., Inc. | 2 | $41 |
| Regeneron Healthcare Solutions, Inc. | 1 | $37 |
| Sobi, Inc | 1 | $31 |
| Intuitive Surgical | 1 | $31 |
| AVEO Pharmaceuticals, Inc. | 1 | $27 |
| Astellas Pharma US Inc | 1 | $26 |
| Iovance Biotherapeutics, Inc. | 1 | $26 |
| Foundation Medicine, Inc. | 1 | $25 |
| Bayer | 1 | $22 |
| AbbVie | 1 | $18 |
| Eisai Inc. | 1 | $16 |
| Coherus Oncology, Inc. | 1 | $15 |
| Genentech USA, Inc. | 1 | $15 |
| Hologic Sales And Service, LLC | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- HemoBlast Bellows$617
- PreciseTumor$227
- SPY-PHI SYSTEM$176
- ZEJULA$122
How this compares
$3,247 in reported general payments places this provider in the 50th percentile of 135 gynecologic oncology providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 50 | $30,139 |
| Megestrol Acetate | 24 | $2,152 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 78 | $1,370 |
| Fentanyl | 13 | $996 |
| Ondansetron Hcl | 42 | $472 |
| Nystatin | 26 | $468 |
| Imiquimod | 15 | $372 |
| Gabapentin | 31 | $300 |
| Dexamethasone | 34 | $263 |
| Oxycodone Hcl | 25 | $240 |
| Estradiol | 12 | $232 |
| Clobetasol Propionate | 12 | $191 |
| Prochlorperazine Maleate | 19 | $168 |
| Letrozole | 16 | $115 |
| Methocarbamol | 12 | $92 |
Paid to pharmacies, not to this prescriber.
Other gynecologic oncology in Arlington
- Robert ColemanHouston$864K
- Reagan StreetFort Worth$280K
- Joseph de la GarzaSan Antonio$234K
- Maurie MarkmanHouston$204K
- Dustin MandersDallas$171K
- Tiffany RedfernFort Worth$165K
- Antonio Santillan-GomezSan Antonio$162K
- Michael FrumovitzHouston$156K
- Eugene ToyEl Paso$138K
- Aparna KamatHouston$116K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.